White Paper

Overcoming The Obstacles Of Spray-Dried Dispersion Scale-Up

Source: Lonza
GettyImages-1417391937-pharmaceutical-spray-drying-with-scientists

SDD scale-up looks straightforward on paper, but the gap between lab-scale feasibility and commercial manufacture is where bioavailability, physical stability, and yield are most at risk. Moving too quickly without the right predictive framework can produce late-stage surprises that are costly to correct.

This white paper examines the technical and operational considerations involved in choosing a scale-up approach and a capable partner, including how material-sparing techniques and model-based tools can characterize drying kinetics, particle formation, and process sensitivities well before late-stage development. A case study involving a molecule with particularly challenging solubility constraints shows how careful spray condition optimization and collaborative study design preserved critical material attributes through GMP manufacturing.

Explore the full analysis to understand what a well-structured SDD scale-up framework requires.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma